Global Intravenous Immunoglobulins Market Research Report 2022(Status and Outlook)

June 2022 | 116 pages | ID: GC3AC2D0259AEN
Bosson Research

Abstracts

Report Overview

The Global Intravenous Immunoglobulins Market Size was estimated at USD 9746.01 million in 2021 and is projected to reach USD 14614.76 million by 2028, exhibiting a CAGR of 5.96% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Intravenous Immunoglobulins market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intravenous Immunoglobulins Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intravenous Immunoglobulins market in any manner.

Global Intravenous Immunoglobulins Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• CSL Behring
• Grifols
• Octapharma
• Takeda
• ADMA Biologics
• Bayer
• Bharat Serum and Vaccines
• Biotest
• China Biologic Products
• Hualan Biological Engineering
• Kedrion Biopharma
• LFB Group
• Sanquin

Market Segmentation (by Type)

• IgG
• IgA
• IgM
• IgE
• IgD

Market Segmentation (by Application)

• Primary Immunodeficiency
• Idiopathic Thrombocytopenic Purpura
• Chronic Inflammatory Demyelinating Polyneuropathy
• Kawasaki Disease
• Guillain-Barre Syndrome
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Intravenous Immunoglobulins Market
• Overview of the regional outlook of the Intravenous Immunoglobulins Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intravenous Immunoglobulins Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Intravenous Immunoglobulins
1.2 Key Market Segments
  1.2.1 Intravenous Immunoglobulins Segment by Type
  1.2.2 Intravenous Immunoglobulins Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 INTRAVENOUS IMMUNOGLOBULINS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Intravenous Immunoglobulins Market Size (M USD) Estimates and Forecasts (2017-2028)
  2.1.2 Global Intravenous Immunoglobulins Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 INTRAVENOUS IMMUNOGLOBULINS MARKET COMPETITIVE LANDSCAPE

3.1 Global Intravenous Immunoglobulins Sales by Manufacturers (2017-2022)
3.2 Global Intravenous Immunoglobulins Revenue Market Share by Manufacturers (2017-2022)
3.3 Intravenous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Intravenous Immunoglobulins Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Intravenous Immunoglobulins Sales Sites, Area Served, Product Type
3.6 Intravenous Immunoglobulins Market Competitive Situation and Trends
  3.6.1 Intravenous Immunoglobulins Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Intravenous Immunoglobulins Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 INTRAVENOUS IMMUNOGLOBULINS INDUSTRY CHAIN ANALYSIS

4.1 Intravenous Immunoglobulins Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF INTRAVENOUS IMMUNOGLOBULINS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 INTRAVENOUS IMMUNOGLOBULINS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Intravenous Immunoglobulins Sales Market Share by Type (2017-2022)
6.3 Global Intravenous Immunoglobulins Market Size Market Share by Type (2017-2022)
6.4 Global Intravenous Immunoglobulins Price by Type (2017-2022)

7 INTRAVENOUS IMMUNOGLOBULINS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Intravenous Immunoglobulins Market Sales by Application (2017-2022)
7.3 Global Intravenous Immunoglobulins Market Size (M USD) by Application (2017-2022)
7.4 Global Intravenous Immunoglobulins Sales Growth Rate by Application (2017-2022)

8 INTRAVENOUS IMMUNOGLOBULINS MARKET SEGMENTATION BY REGION

8.1 Global Intravenous Immunoglobulins Sales by Region
  8.1.1 Global Intravenous Immunoglobulins Sales by Region
  8.1.2 Global Intravenous Immunoglobulins Sales Market Share by Region
8.2 North America
  8.2.1 North America Intravenous Immunoglobulins Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Intravenous Immunoglobulins Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Intravenous Immunoglobulins Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Intravenous Immunoglobulins Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Intravenous Immunoglobulins Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 CSL Behring
  9.1.1 CSL Behring Intravenous Immunoglobulins Basic Information
  9.1.2 CSL Behring Intravenous Immunoglobulins Product Overview
  9.1.3 CSL Behring Intravenous Immunoglobulins Product Market Performance
  9.1.4 CSL Behring Business Overview
  9.1.5 CSL Behring Intravenous Immunoglobulins SWOT Analysis
  9.1.6 CSL Behring Recent Developments
9.2 Grifols
  9.2.1 Grifols Intravenous Immunoglobulins Basic Information
  9.2.2 Grifols Intravenous Immunoglobulins Product Overview
  9.2.3 Grifols Intravenous Immunoglobulins Product Market Performance
  9.2.4 Grifols Business Overview
  9.2.5 Grifols Intravenous Immunoglobulins SWOT Analysis
  9.2.6 Grifols Recent Developments
9.3 Octapharma
  9.3.1 Octapharma Intravenous Immunoglobulins Basic Information
  9.3.2 Octapharma Intravenous Immunoglobulins Product Overview
  9.3.3 Octapharma Intravenous Immunoglobulins Product Market Performance
  9.3.4 Octapharma Business Overview
  9.3.5 Octapharma Intravenous Immunoglobulins SWOT Analysis
  9.3.6 Octapharma Recent Developments
9.4 Takeda
  9.4.1 Takeda Intravenous Immunoglobulins Basic Information
  9.4.2 Takeda Intravenous Immunoglobulins Product Overview
  9.4.3 Takeda Intravenous Immunoglobulins Product Market Performance
  9.4.4 Takeda Business Overview
  9.4.5 Takeda Intravenous Immunoglobulins SWOT Analysis
  9.4.6 Takeda Recent Developments
9.5 ADMA Biologics
  9.5.1 ADMA Biologics Intravenous Immunoglobulins Basic Information
  9.5.2 ADMA Biologics Intravenous Immunoglobulins Product Overview
  9.5.3 ADMA Biologics Intravenous Immunoglobulins Product Market Performance
  9.5.4 ADMA Biologics Business Overview
  9.5.5 ADMA Biologics Intravenous Immunoglobulins SWOT Analysis
  9.5.6 ADMA Biologics Recent Developments
9.6 Bayer
  9.6.1 Bayer Intravenous Immunoglobulins Basic Information
  9.6.2 Bayer Intravenous Immunoglobulins Product Overview
  9.6.3 Bayer Intravenous Immunoglobulins Product Market Performance
  9.6.4 Bayer Business Overview
  9.6.5 Bayer Recent Developments
9.7 Bharat Serum and Vaccines
  9.7.1 Bharat Serum and Vaccines Intravenous Immunoglobulins Basic Information
  9.7.2 Bharat Serum and Vaccines Intravenous Immunoglobulins Product Overview
  9.7.3 Bharat Serum and Vaccines Intravenous Immunoglobulins Product Market Performance
  9.7.4 Bharat Serum and Vaccines Business Overview
  9.7.5 Bharat Serum and Vaccines Recent Developments
9.8 Biotest
  9.8.1 Biotest Intravenous Immunoglobulins Basic Information
  9.8.2 Biotest Intravenous Immunoglobulins Product Overview
  9.8.3 Biotest Intravenous Immunoglobulins Product Market Performance
  9.8.4 Biotest Business Overview
  9.8.5 Biotest Recent Developments
9.9 China Biologic Products
  9.9.1 China Biologic Products Intravenous Immunoglobulins Basic Information
  9.9.2 China Biologic Products Intravenous Immunoglobulins Product Overview
  9.9.3 China Biologic Products Intravenous Immunoglobulins Product Market Performance
  9.9.4 China Biologic Products Business Overview
  9.9.5 China Biologic Products Recent Developments
9.10 Hualan Biological Engineering
  9.10.1 Hualan Biological Engineering Intravenous Immunoglobulins Basic Information
  9.10.2 Hualan Biological Engineering Intravenous Immunoglobulins Product Overview
  9.10.3 Hualan Biological Engineering Intravenous Immunoglobulins Product Market Performance
  9.10.4 Hualan Biological Engineering Business Overview
  9.10.5 Hualan Biological Engineering Recent Developments
9.11 Kedrion Biopharma
  9.11.1 Kedrion Biopharma Intravenous Immunoglobulins Basic Information
  9.11.2 Kedrion Biopharma Intravenous Immunoglobulins Product Overview
  9.11.3 Kedrion Biopharma Intravenous Immunoglobulins Product Market Performance
  9.11.4 Kedrion Biopharma Business Overview
  9.11.5 Kedrion Biopharma Recent Developments
9.12 LFB Group
  9.12.1 LFB Group Intravenous Immunoglobulins Basic Information
  9.12.2 LFB Group Intravenous Immunoglobulins Product Overview
  9.12.3 LFB Group Intravenous Immunoglobulins Product Market Performance
  9.12.4 LFB Group Business Overview
  9.12.5 LFB Group Recent Developments
9.13 Sanquin
  9.13.1 Sanquin Intravenous Immunoglobulins Basic Information
  9.13.2 Sanquin Intravenous Immunoglobulins Product Overview
  9.13.3 Sanquin Intravenous Immunoglobulins Product Market Performance
  9.13.4 Sanquin Business Overview
  9.13.5 Sanquin Recent Developments

10 INTRAVENOUS IMMUNOGLOBULINS MARKET FORECAST BY REGION

10.1 Global Intravenous Immunoglobulins Market Size Forecast
10.2 Global Intravenous Immunoglobulins Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Intravenous Immunoglobulins Market Size Forecast by Country
  10.2.3 Asia Pacific Intravenous Immunoglobulins Market Size Forecast by Region
  10.2.4 South America Intravenous Immunoglobulins Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Intravenous Immunoglobulins by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)

11.1 Global Intravenous Immunoglobulins Market Forecast by Type (2022-2028)
  11.1.1 Global Forecasted Sales of Intravenous Immunoglobulins by Type (2022-2028)
  11.1.2 Global Intravenous Immunoglobulins Market Size Forecast by Type (2022-2028)
  11.1.3 Global Forecasted Price of Intravenous Immunoglobulins by Type (2022-2028)
11.2 Global Intravenous Immunoglobulins Market Forecast by Application (2022-2028)
  11.2.1 Global Intravenous Immunoglobulins Sales (K Units) Forecast by Application
  11.2.2 Global Intravenous Immunoglobulins Market Size (M USD) Forecast by Application (2022-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Intravenous Immunoglobulins Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Intravenous Immunoglobulins Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Intravenous Immunoglobulins Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Intravenous Immunoglobulins Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Intravenous Immunoglobulins Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulins as of 2021)
Table 10. Global Market Intravenous Immunoglobulins Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Intravenous Immunoglobulins Sales Sites and Area Served
Table 12. Manufacturers Intravenous Immunoglobulins Product Type
Table 13. Global Intravenous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Intravenous Immunoglobulins
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Intravenous Immunoglobulins Market Challenges
Table 22. Market Restraints
Table 23. Global Intravenous Immunoglobulins Sales by Type (K Units)
Table 24. Global Intravenous Immunoglobulins Market Size by Type (M USD)
Table 25. Global Intravenous Immunoglobulins Sales (K Units) by Type (2017-2022)
Table 26. Global Intravenous Immunoglobulins Sales Market Share by Type (2017-2022)
Table 27. Global Intravenous Immunoglobulins Market Size (M USD) by Type (2017-2022)
Table 28. Global Intravenous Immunoglobulins Market Size Share by Type (2017-2022)
Table 29. Global Intravenous Immunoglobulins Price (USD/Unit) by Type (2017-2022)
Table 30. Global Intravenous Immunoglobulins Sales (K Units) by Application
Table 31. Global Intravenous Immunoglobulins Market Size by Application
Table 32. Global Intravenous Immunoglobulins Sales by Application (2017-2022) & (K Units)
Table 33. Global Intravenous Immunoglobulins Sales Market Share by Application (2017-2022)
Table 34. Global Intravenous Immunoglobulins Sales by Application (2017-2022) & (M USD)
Table 35. Global Intravenous Immunoglobulins Market Share by Application (2017-2022)
Table 36. Global Intravenous Immunoglobulins Sales Growth Rate by Application (2017-2022)
Table 37. Global Intravenous Immunoglobulins Sales by Region (2017-2022) & (K Units)
Table 38. Global Intravenous Immunoglobulins Sales Market Share by Region (2017-2022)
Table 39. North America Intravenous Immunoglobulins Sales by Country (2017-2022) & (K Units)
Table 40. Europe Intravenous Immunoglobulins Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Intravenous Immunoglobulins Sales by Region (2017-2022) & (K Units)
Table 42. South America Intravenous Immunoglobulins Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Intravenous Immunoglobulins Sales by Region (2017-2022) & (K Units)
Table 44. CSL Behring Intravenous Immunoglobulins Basic Information
Table 45. CSL Behring Intravenous Immunoglobulins Product Overview
Table 46. CSL Behring Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. CSL Behring Business Overview
Table 48. CSL Behring Intravenous Immunoglobulins SWOT Analysis
Table 49. CSL Behring Recent Developments
Table 50. Grifols Intravenous Immunoglobulins Basic Information
Table 51. Grifols Intravenous Immunoglobulins Product Overview
Table 52. Grifols Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Grifols Business Overview
Table 54. Grifols Intravenous Immunoglobulins SWOT Analysis
Table 55. Grifols Recent Developments
Table 56. Octapharma Intravenous Immunoglobulins Basic Information
Table 57. Octapharma Intravenous Immunoglobulins Product Overview
Table 58. Octapharma Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Octapharma Business Overview
Table 60. Octapharma Intravenous Immunoglobulins SWOT Analysis
Table 61. Octapharma Recent Developments
Table 62. Takeda Intravenous Immunoglobulins Basic Information
Table 63. Takeda Intravenous Immunoglobulins Product Overview
Table 64. Takeda Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Takeda Business Overview
Table 66. Takeda Intravenous Immunoglobulins SWOT Analysis
Table 67. Takeda Recent Developments
Table 68. ADMA Biologics Intravenous Immunoglobulins Basic Information
Table 69. ADMA Biologics Intravenous Immunoglobulins Product Overview
Table 70. ADMA Biologics Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. ADMA Biologics Business Overview
Table 72. ADMA Biologics Intravenous Immunoglobulins SWOT Analysis
Table 73. ADMA Biologics Recent Developments
Table 74. Bayer Intravenous Immunoglobulins Basic Information
Table 75. Bayer Intravenous Immunoglobulins Product Overview
Table 76. Bayer Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Bayer Business Overview
Table 78. Bayer Recent Developments
Table 79. Bharat Serum and Vaccines Intravenous Immunoglobulins Basic Information
Table 80. Bharat Serum and Vaccines Intravenous Immunoglobulins Product Overview
Table 81. Bharat Serum and Vaccines Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Bharat Serum and Vaccines Business Overview
Table 83. Bharat Serum and Vaccines Recent Developments
Table 84. Biotest Intravenous Immunoglobulins Basic Information
Table 85. Biotest Intravenous Immunoglobulins Product Overview
Table 86. Biotest Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Biotest Business Overview
Table 88. Biotest Recent Developments
Table 89. China Biologic Products Intravenous Immunoglobulins Basic Information
Table 90. China Biologic Products Intravenous Immunoglobulins Product Overview
Table 91. China Biologic Products Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. China Biologic Products Business Overview
Table 93. China Biologic Products Recent Developments
Table 94. Hualan Biological Engineering Intravenous Immunoglobulins Basic Information
Table 95. Hualan Biological Engineering Intravenous Immunoglobulins Product Overview
Table 96. Hualan Biological Engineering Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Hualan Biological Engineering Business Overview
Table 98. Hualan Biological Engineering Recent Developments
Table 99. Kedrion Biopharma Intravenous Immunoglobulins Basic Information
Table 100. Kedrion Biopharma Intravenous Immunoglobulins Product Overview
Table 101. Kedrion Biopharma Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Kedrion Biopharma Business Overview
Table 103. Kedrion Biopharma Recent Developments
Table 104. LFB Group Intravenous Immunoglobulins Basic Information
Table 105. LFB Group Intravenous Immunoglobulins Product Overview
Table 106. LFB Group Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. LFB Group Business Overview
Table 108. LFB Group Recent Developments
Table 109. Sanquin Intravenous Immunoglobulins Basic Information
Table 110. Sanquin Intravenous Immunoglobulins Product Overview
Table 111. Sanquin Intravenous Immunoglobulins Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Sanquin Business Overview
Table 113. Sanquin Recent Developments
Table 114. Global Intravenous Immunoglobulins Sales Forecast by Region (K Units)
Table 115. Global Intravenous Immunoglobulins Market Size Forecast by Region (M USD)
Table 116. North America Intravenous Immunoglobulins Sales Forecast by Country (2022-2028) & (K Units)
Table 117. North America Intravenous Immunoglobulins Market Size Forecast by Country (2022-2028) & (M USD)
Table 118. Europe Intravenous Immunoglobulins Sales Forecast by Country (2022-2028) & (K Units)
Table 119. Europe Intravenous Immunoglobulins Market Size Forecast by Country (2022-2028) & (M USD)
Table 120. Asia Pacific Intravenous Immunoglobulins Sales Forecast by Region (2022-2028) & (K Units)
Table 121. Asia Pacific Intravenous Immunoglobulins Market Size Forecast by Region (2022-2028) & (M USD)
Table 122. South America Intravenous Immunoglobulins Sales Forecast by Country (2022-2028) & (K Units)
Table 123. South America Intravenous Immunoglobulins Market Size Forecast by Country (2022-2028) & (M USD)
Table 124. Middle East and Africa Intravenous Immunoglobulins Consumption Forecast by Country (2022-2028) & (Units)
Table 125. Middle East and Africa Intravenous Immunoglobulins Market Size Forecast by Country (2022-2028) & (M USD)
Table 126. Global Intravenous Immunoglobulins Sales Forecast by Type (2022-2028) & (K Units)
Table 127. Global Intravenous Immunoglobulins Market Size Forecast by Type (2022-2028) & (M USD)
Table 128. Global Intravenous Immunoglobulins Price Forecast by Type (2022-2028) & (USD/Unit)
Table 129. Global Intravenous Immunoglobulins Sales (K Units) Forecast by Application (2022-2028)
Table 130. Global Intravenous Immunoglobulins Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Intravenous Immunoglobulins
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Intravenous Immunoglobulins Market Size (M USD), 2017-2028
Figure 5. Global Intravenous Immunoglobulins Market Size (M USD) (2017-2028)
Figure 6. Global Intravenous Immunoglobulins Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Intravenous Immunoglobulins Market Size (M USD) by Country (M USD)
Figure 11. Intravenous Immunoglobulins Sales Share by Manufacturers in 2020
Figure 12. Global Intravenous Immunoglobulins Revenue Share by Manufacturers in 2020
Figure 13. Intravenous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Intravenous Immunoglobulins Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Intravenous Immunoglobulins Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Intravenous Immunoglobulins Market Share by Type
Figure 18. Sales Market Share of Intravenous Immunoglobulins by Type (2017-2022)
Figure 19. Sales Market Share of Intravenous Immunoglobulins by Type in 2021
Figure 20. Market Size Share of Intravenous Immunoglobulins by Type (2017-2022)
Figure 21. Market Size Market Share of Intravenous Immunoglobulins by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Intravenous Immunoglobulins Market Share by Application
Figure 24. Global Intravenous Immunoglobulins Sales Market Share by Application (2017-2022)
Figure 25. Global Intravenous Immunoglobulins Sales Market Share by Application in 2021
Figure 26. Global Intravenous Immunoglobulins Market Share by Application (2017-2022)
Figure 27. Global Intravenous Immunoglobulins Market Share by Application in 2020
Figure 28. Global Intravenous Immunoglobulins Sales Growth Rate by Application (2017-2022)
Figure 29. Global Intravenous Immunoglobulins Sales Market Share by Region (2017-2022)
Figure 30. North America Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Intravenous Immunoglobulins Sales Market Share by Country in 2020
Figure 32. U.S. Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Intravenous Immunoglobulins Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Intravenous Immunoglobulins Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Intravenous Immunoglobulins Sales Market Share by Country in 2020
Figure 37. Germany Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Intravenous Immunoglobulins Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Intravenous Immunoglobulins Sales Market Share by Region in 2020
Figure 44. China Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Intravenous Immunoglobulins Sales and Growth Rate (K Units)
Figure 50. South America Intravenous Immunoglobulins Sales Market Share by Country in 2020
Figure 51. Brazil Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Intravenous Immunoglobulins Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Intravenous Immunoglobulins Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Intravenous Immunoglobulins Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Intravenous Immunoglobulins Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Intravenous Immunoglobulins Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Intravenous Immunoglobulins Market Share Forecast by Type (2022-2028)
Figure 65. Global Intravenous Immunoglobulins Sales Forecast by Application (2022-2028)
Figure 66. Global Intravenous Immunoglobulins Market Share Forecast by Application (2022-2028)